| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
41,322 |
39,835 |
$6.27M |
| S4993 |
Contraceptive pills for birth control |
57,662 |
51,352 |
$6.08M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,726 |
37,881 |
$2.47M |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
2,916 |
2,903 |
$1.16M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
10,191 |
9,853 |
$571K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
2,211 |
2,203 |
$510K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,307 |
8,809 |
$406K |
| 81025 |
|
54,433 |
51,462 |
$377K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,160 |
4,032 |
$362K |
| S9430 |
Pharmacy compounding and dispensing services |
4,391 |
4,217 |
$326K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,189 |
3,043 |
$290K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
12,407 |
12,373 |
$209K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
10,853 |
10,715 |
$160K |
| S4930 |
|
16,270 |
15,827 |
$160K |
| J7300 |
Intrauterine copper contraceptive (paragard) |
597 |
595 |
$147K |
| 87806 |
|
6,659 |
6,519 |
$146K |
| A4267 |
Contraceptive supply, condom, male, each |
26,578 |
25,273 |
$95K |
| 86703 |
|
10,509 |
9,611 |
$94K |
| 55250 |
|
125 |
122 |
$88K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,565 |
4,416 |
$61K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,830 |
1,820 |
$43K |
| 36415 |
Collection of venous blood by venipuncture |
10,203 |
9,633 |
$39K |
| 36416 |
|
19,818 |
18,897 |
$35K |
| J7303 |
Contraceptive supply, hormone containing vaginal ring, each |
1,364 |
1,349 |
$30K |
| 57454 |
|
228 |
224 |
$29K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
461 |
411 |
$27K |
| 58300 |
|
118 |
113 |
$27K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
4,143 |
3,237 |
$23K |
| 87210 |
|
5,015 |
4,787 |
$20K |
| 11981 |
|
62 |
62 |
$12K |
| S5000 |
Prescription drug, generic |
2,667 |
2,145 |
$12K |
| 82120 |
|
2,601 |
2,527 |
$11K |
| 99000 |
|
19,298 |
18,659 |
$8K |
| J7296 |
Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg |
37 |
37 |
$8K |
| 83986 |
|
2,556 |
2,446 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
53 |
53 |
$7K |
| Q3014 |
Telehealth originating site facility fee |
213 |
204 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
40 |
38 |
$4K |
| 99201 |
|
123 |
122 |
$4K |
| 11982 |
|
24 |
24 |
$2K |
| J7295 |
Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each |
73 |
70 |
$916.47 |
| 58301 |
|
14 |
13 |
$660.96 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
29 |
28 |
$304.50 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
12 |
$262.50 |
| 81002 |
|
75 |
74 |
$213.90 |
| 85018 |
|
33 |
31 |
$40.81 |